SCP-486
Safe
✓
high confidence
SCP-486
Expected annual
$1.4M
One-time setup
$2.4M
Annual recurring
$1.3M
Personnel
10
One-time capital and research setup is moderate (~$2.37M dominated by an optional antivenom R&D fund); annual recurring costs are substantial (~$1.29M/yr) and are dominated by personnel (security and medical) plus ongoing research, insurance, and contingency reserves.
One-Time Capital Costs
Total: $2.4M
Annual Recurring Costs
Total: $1.3M/yr
Cost Scenarios
📊
Baseline
(baseline)
$1.3M/yr
Normal year with routine operations, no major incidents or decided scale-up of antivenom R&D.
routine_operations
no_major_incidents
🚨
Minor Incident
$1.3M/yr
Single self-harm event or localized medical emergency requiring overtime, medevac, extra disposables and minor repairs.
self-harm_event
emergency_medical_evac
increased_overtime
🚨
Major Breach
$1.8M/yr
Serious containment breach or multiple envenomations causing hospitalizations, legal actions, forensic investigation and containment repairs.
containment_breach
multiple_envenomations
legal_and_PR_response
🚨
Antivenom Development
$2.8M/yr
Decision/year in which Foundation scales up R&D to develop a specific antivenom and associated GMP/manufacturing planning.
decision_to_pursue_antivenom
scale_up_R&D
GMP_manufacturing_planning
Personnel
10 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 8 | [#1] Eight full-time-equivalent Level-1 guards to provide any-two-on-duty 24/7 coverage (covers three shifts plus leave/benefits). |
| Medical Officer | 2 | [#3] Two Level-2 medical staff allocation trained in venomous reptile handling (pro rata allocation from site medical staff). |
Confidence Notes
Analyst notes provide detailed line items and explicit ranges for salaries, equipment, training, and R&D; estimates use midpoints and documented figures (e.g., guard payroll). Remaining uncertainty arises mainly from optional antivenom R&D scale decisions.